BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 23804077)

  • 1. Downregulation of Stat3 in melanoma: reprogramming the immune microenvironment as an anticancer therapeutic strategy.
    Emeagi PU; Maenhout S; Dang N; Heirman C; Thielemans K; Breckpot K
    Gene Ther; 2013 Nov; 20(11):1085-92. PubMed ID: 23804077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Delivery of interferons and siRNA targeting STAT3 using lentiviral vectors suppresses the growth of murine melanoma.
    Wang X; Liu P; Liu H; Yang W; Liu Z; Zhuo Z; Gao Y
    Cancer Gene Ther; 2012 Dec; 19(12):822-7. PubMed ID: 23018621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. STAT3 silencing in dendritic cells by siRNA polyplexes encapsulated in PLGA nanoparticles for the modulation of anticancer immune response.
    Alshamsan A; Haddadi A; Hamdy S; Samuel J; El-Kadi AO; Uludağ H; Lavasanifar A
    Mol Pharm; 2010 Oct; 7(5):1643-54. PubMed ID: 20804176
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced cancer immunotherapy using STAT3-depleted dendritic cells with high Th1-inducing ability and resistance to cancer cell-derived inhibitory factors.
    Iwata-Kajihara T; Sumimoto H; Kawamura N; Ueda R; Takahashi T; Mizuguchi H; Miyagishi M; Takeda K; Kawakami Y
    J Immunol; 2011 Jul; 187(1):27-36. PubMed ID: 21632716
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CCR5 Blockade Suppresses Melanoma Development Through Inhibition of IL-6-Stat3 Pathway via Upregulation of SOCS3.
    Tang Q; Jiang J; Liu J
    Inflammation; 2015 Dec; 38(6):2049-56. PubMed ID: 26047948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of STAT3 potentiates growth, survival, and radioresistance of non-small-cell lung cancer (NSCLC) cells.
    Yin ZJ; Jin FG; Liu TG; Fu EQ; Xie YH; Sun RL
    J Surg Res; 2011 Dec; 171(2):675-83. PubMed ID: 20605584
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Icariside II induces apoptosis of melanoma cells through the downregulation of survival pathways.
    Wu J; Xu J; Eksioglu EA; Chen X; Zhou J; Fortenbery N; Wei S; Dong J
    Nutr Cancer; 2013; 65(1):110-7. PubMed ID: 23368920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The induction of tumor apoptosis in B16 melanoma following STAT3 siRNA delivery with a lipid-substituted polyethylenimine.
    Alshamsan A; Hamdy S; Samuel J; El-Kadi AO; Lavasanifar A; Uludağ H
    Biomaterials; 2010 Feb; 31(6):1420-8. PubMed ID: 19913908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancement of cancer vaccine therapy by systemic delivery of a tumor-targeting Salmonella-based STAT3 shRNA suppresses the growth of established melanoma tumors.
    Manuel ER; Blache CA; Paquette R; Kaltcheva TI; Ishizaki H; Ellenhorn JD; Hensel M; Metelitsa L; Diamond DJ
    Cancer Res; 2011 Jun; 71(12):4183-91. PubMed ID: 21527558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Downregulation of RIG-I mediated by ITGB3/c-SRC/STAT3 signaling confers resistance to interferon-α-induced apoptosis in tumor-repopulating cells of melanoma.
    Li Y; Song Y; Li P; Li M; Wang H; Xu T; Yu X; Yu Y; Tai Y; Chen P; Cai X; Wang X; Xiang L; Deng R; Zhang X; Gao L; Wang X; Liu J; Cao F
    J Immunother Cancer; 2020 Mar; 8(1):. PubMed ID: 32152220
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SIPAR negatively regulates STAT3 signaling and inhibits progression of melanoma.
    Ren F; Su F; Ning H; Wang Y; Geng Y; Feng Y; Wang Y; Zhang Y; Jin Z; Li Y; Jia B; Chang Z
    Cell Signal; 2013 Nov; 25(11):2272-80. PubMed ID: 23917203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of prostate cancer RM1 cell growth in vitro by hydroxyapatite nanoparticle‑delivered short hairpin RNAs against Stat3.
    Liang Z; Wang H; Guo B; Li F; Liu J; Liu Z; Xu L; Yun W; Zhao X; Zhang L
    Mol Med Rep; 2017 Jul; 16(1):459-465. PubMed ID: 28534932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum amyloid A3 exacerbates cancer by enhancing the suppressive capacity of myeloid-derived suppressor cells via TLR2-dependent STAT3 activation.
    Lee JM; Kim EK; Seo H; Jeon I; Chae MJ; Park YJ; Song B; Kim YS; Kim YJ; Ko HJ; Kang CY
    Eur J Immunol; 2014 Jun; 44(6):1672-84. PubMed ID: 24659444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of cervical cancer cell growth in vitro and in vivo with lentiviral-vector delivered short hairpin RNA targeting human papillomavirus E6 and E7 oncogenes.
    Gu W; Putral L; Hengst K; Minto K; Saunders NA; Leggatt G; McMillan NA
    Cancer Gene Ther; 2006 Nov; 13(11):1023-32. PubMed ID: 16810314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene therapy with dominant-negative Stat3 suppresses growth of the murine melanoma B16 tumor in vivo.
    Niu G; Heller R; Catlett-Falcone R; Coppola D; Jaroszeski M; Dalton W; Jove R; Yu H
    Cancer Res; 1999 Oct; 59(20):5059-63. PubMed ID: 10537273
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of the STAT3 signaling pathway contributes to apigenin-mediated anti-metastatic effect in melanoma.
    Cao HH; Chu JH; Kwan HY; Su T; Yu H; Cheng CY; Fu XQ; Guo H; Li T; Tse AK; Chou GX; Mo HB; Yu ZL
    Sci Rep; 2016 Feb; 6():21731. PubMed ID: 26911838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. STAT3-targeting RNA interference inhibits pancreatic cancer angiogenesis in vitro and in vivo.
    Huang C; Jiang T; Zhu L; Liu J; Cao J; Huang KJ; Qiu ZJ
    Int J Oncol; 2011 Jun; 38(6):1637-44. PubMed ID: 21479358
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of drug delivery and anticancer potentials of nanoparticles-loaded siRNA targeting STAT3 in lung cancer, in vitro and in vivo.
    Das J; Das S; Paul A; Samadder A; Bhattacharyya SS; Khuda-Bukhsh AR
    Toxicol Lett; 2014 Mar; 225(3):454-66. PubMed ID: 24440344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Down-regulation of signal transducer and activator of transcription 3 expression using vector-based small interfering RNAs suppresses growth of human prostate tumor in vivo.
    Gao L; Zhang L; Hu J; Li F; Shao Y; Zhao D; Kalvakolanu DV; Kopecko DJ; Zhao X; Xu DQ
    Clin Cancer Res; 2005 Sep; 11(17):6333-41. PubMed ID: 16144938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of RNAi-mediated STAT3 gene inhibition on metastasis of human pancreatic cancer cells].
    Gao Z; Huang C; Qiu ZJ; Jiang T; Zhu L; Cao J; Zhang F; Huang KJ
    Zhonghua Wai Ke Za Zhi; 2008 Jul; 46(13):1010-3. PubMed ID: 19035205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.